| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006027397A1 Spiropiperidyl rifamycins for the treatment of microbacterial infections |
| 03/16/2006 | US20060058330 Rylene derivatives and their use as dyes |
| 03/16/2006 | US20060058321 Enzyme inhibitors for kinases and antitumor agents with bicyclic or tricyclic compounds with thiophene ring |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058287 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578164A1 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
| 03/16/2006 | CA2565235A1 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/15/2006 | EP1634873A1 Sigma receptor inhibitors |
| 03/15/2006 | EP1634596A1 Aporphine and oxoaporphine and the medical use thereof |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633731A2 Thiocarbamate inhibitors of alpha-4 integrins |
| 03/15/2006 | EP1633728A1 2-substituted pyrimidines |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633362A2 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | CN1747943A Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 03/15/2006 | CN1747938A Novel substituted 2,3-benzodiazepine derivatives |
| 03/15/2006 | CN1245408C Use of Maituolaicin |
| 03/15/2006 | CN1245406C Method for extracting tetrodotoxin from globefish livers |
| 03/14/2006 | US7012142 Sultam compounds |
| 03/14/2006 | US7012090 Pyranoindoles for treating glaucoma |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012079 (5R)-5-ethyl-9,10,difluoro-5-hydroxy-12-(2-trimethylsilylethyl)-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]-indoloizino[1,2-b]quinoline-3,15-dione for treatment of colon cancer |
| 03/14/2006 | US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc. |
| 03/14/2006 | CA2380810C Pyridomorphinans and use thereof |
| 03/14/2006 | CA2210631C Tricyclic benzazepine vasopressin antagonists |
| 03/14/2006 | CA2165800C Antiallergic imidazoazepines |
| 03/09/2006 | WO2006026430A2 Cyclopamine analogues and methods of use thereof |
| 03/09/2006 | WO2006025859A2 Methods, compositions, and apparatuses for forming macrocyclic compounds |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006024666A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 03/09/2006 | US20060052463 stirring with excess of aluminum chloride and sulfuric acid |
| 03/09/2006 | US20060052424 Lactacystin analogs |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052410 3,9-Dimethoxy-6H-chromeno[4,3-b]quinolin-7-ol; selective estrogen receptor beta modulators; diseases mediated by an estrogen deficiency or excess: osteoporosis, Crohn's disease, ulcerative proctitis, colitis, estrogen dependent cancers, hypercholesteremia, atherosclerosis, Alzheimer's disease |
| 03/09/2006 | US20060052409 Therapeutic or preventive agent for nausea/vomiting |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052392 Isoindoline derivative |
| 03/09/2006 | US20060052381 Solubilized topoisomerase poisons |
| 03/09/2006 | US20060052374 Amino-tetrazole analogues and methods of use |
| 03/09/2006 | US20060051791 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/09/2006 | US20060051758 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 03/09/2006 | US20060051612 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
| 03/09/2006 | US20060049064 Process for electrochemical oxidation of ferrocyanide to ferricyanide |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2576765A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 03/09/2006 | CA2557582A1 Methods, compositions, and apparatuses for forming macrocyclic compounds |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1390371B1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP0891330B1 Substituted phenyl keto enols as pesticides and herbicides |
| 03/08/2006 | CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/08/2006 | CN1244585C Synthesis of silicyl camptothecins and silicyl homo camptothecins |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/07/2006 | US7008950 For example 3-(4-Isopropylphenyl)-5-(4-methoxybenzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran and its synthesis; suppress cell toxicities caused by beta-amyloid protein, protect nerve cells |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008944 Treating obsessive compulsive disorder, panic attacks, sexual disorders, eating disorders, obesity, drug abuse and ethanol or cocaine dependence; anxiolytic agents |
| 03/07/2006 | US7008940 1,6,7,8-tetrahydro-2,2,4,5-tetramethyl-1-(4-methylphenyl)-2H-furo[3,2-e]indole for example; inhibiting lipoperoxide production (antioxidant); treating restenosis after percutaneous transluminal coronary angioplasty; Alzheimer's disease |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008759 Dyes and use thereof in imaging members and methods |
| 03/02/2006 | WO2006023467A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ |
| 03/02/2006 | WO2006022773A1 Gyrase inhibitors and uses thereof |
| 03/02/2006 | WO2005121148A3 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
| 03/02/2006 | WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| 03/02/2006 | US20060047128 (R)-O,O'-(9,9'-Spirobixanthene-1,1'-diyl)-N,N-Dimethylphosphoramide [(R)-4] ligand forms hydrogenation catalyst with Rh compounds for asymmetrical hydrogenation of olefins, imines, enamides and ketones |
| 03/02/2006 | US20060047120 New method for preparing tiotropium salts |
| 03/02/2006 | US20060047119 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 03/02/2006 | US20060046993 Crystalline polymorphic form of irinotecan hydrochloride |
| 03/02/2006 | US20060046983 Inhibitors of HCV replication |
| 03/02/2006 | US20060046977 Furanopyridine derivatives and methods of use |
| 03/02/2006 | CA2577089A1 Sigma receptor inhibitors |
| 03/01/2006 | EP1628982A2 Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1430059B1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 03/01/2006 | EP1392292B1 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP0842923B1 Pyrrole derivatives and medicinal composition |
| 03/01/2006 | CN1742013A Pyrazolopyrimidine compound and method for producing the same |
| 03/01/2006 | CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors |
| 03/01/2006 | CN1742001A Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 03/01/2006 | CN1741995A Isoindoline derivative |
| 03/01/2006 | CN1740175A Plumepoppy total alkaloid salt and its prepn and application |
| 03/01/2006 | CN1740174A Prepn process of 1,8-disubstituent-1,3,4,9-tetrahydropyran (3,4-b)-indolyl-1-acetate |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006020082A1 Inhibitors of hcv replication |